Kenerson et al. reported immunohistochemical evidence of mTORC1 activity in 15 PEComas and absence of AKT phosphorylation in 14 tumors, which suggests the loss of TSC1 or TSC2 as potential mechanisms[11]. This evidence concerns the gene TSC2 and neoplasm with perivascular epithelioid cell differentiation.